February, 2024
February 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
26272829  
Ishwaria Subbiah: Check out our study where we developed and validated a new PRO tool specifically for symptom burden after cellular therapy!
Sep 19, 2023, 09:30

Ishwaria Subbiah: Check out our study where we developed and validated a new PRO tool specifically for symptom burden after cellular therapy!

Ishwaria Subbiah, shared the following on X/Twitter:

“Supportive care oncology x blood cancer collaborations are just the best — check out our study where we developed and validated a new PRO tool specifically for symptom burden after cellular therapy!

Objective symptom assessments are a key step to mitigate variabilities (i.e. inequities) in outcomes by removing key points where bias (in all its forms) may enter the care delivery continuum.

This is Equity In Action!”

For the article click here.
Source: Ishwaria Subbiah/Twitter

Ishwaria Subbiah is the Executive Director for Cancer Care Equity and Professional Wellness at Sarah Cannon Research Institute (SCRI). In this role, Dr. Subbiah focuses on reducing cancer outcomes disparities and diversifying clinical trial participation within SCRI’s combined research network of over more than 1,300 physicians at over 250 locations in 24 states across the US. Dr. Subbiah is a globally recognized expert in geriatric oncology, symptom management, palliative care, and healthcare professional well-being. She previously was an associate professor in the Division of Cancer Medicine at the University of Texas MD Anderson Cancer Center. She is the Chair for the ASCO Women in Oncology working group and the ASCO State of Cancer Care in America initiative.